Ratnatris Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
as on 19-12-2024
- Paid Up Capital ₹ 3.75 Cr
as on 19-12-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 72.30 Cr
as on 19-12-2024
- Satisfied Charges ₹ 10.25 Cr
as on 19-12-2024
- Revenue 2.12%
(FY 2022)
- Profit -92.86%
(FY 2022)
- Ebitda -119.89%
(FY 2022)
- Net Worth 155.83%
(FY 2022)
- Total Assets 7.55%
(FY 2022)
About Ratnatris Pharmaceuticals
The Corporate was formerly known as Ratnamani Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 3.75 Cr.
The company currently has active open charges totaling ₹72.30 Cr. The company has closed loans amounting to ₹10.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Udayan Choksi, Rishabh Sanghvi, Arpit Shah, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PTC047394
- Company No.
047394
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ratnatris Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishabh Sanghvi  | Director | 17-Dec-2022 | Current |
| Arpit Shah | Director | 15-Jan-2021 | Current |
| Udayan Choksi | Director | 12-Jun-2024 | Current |
| Swapnil Shah | Director | 15-Jan-2021 | Current |
| Kalpit Gandhi | Director | 12-Jun-2024 | Current |
| Jitendra Sanghvi | Director | 11-Aug-2009 | Current |
Financial Performance and Corporate Structure Insights of Ratnatris Pharmaceuticals.
Ratnatris Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.12% increase. The company also saw a substantial fall in profitability, with a 92.86% decrease in profit. The company's net worth Soared by an impressive increase of 155.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ratnatris Pharmaceuticals?
In 2022, Ratnatris Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Senores Pharmaceuticals LimitedActive 6 years 11 monthsUdayan Choksi, Arpit Shah and 3 more are mutual person
Relius Lifesciences Private LimitedActive 8 years 29 daysArpit Shah and Swapnil Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Jun 2023 | ₹2.20 M | Open |
Hdfc Bank Limited Creation Date: 23 Jun 2023 | ₹40.00 Cr | Open |
Hdfc Bank Limited Creation Date: 09 Sep 2022 | ₹8.00 M | Open |
How Many Employees Work at Ratnatris Pharmaceuticals?
Ratnatris Pharmaceuticals has a workforce of 332 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ratnatris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ratnatris Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
